Livingstone Health Holdings Full Year 2025 Earnings: EPS: S$0.001 (vs S$0.006 loss in FY 2024)
Key Financial Results
Revenue: S$27.7m (up 8.9% from FY 2024).
Net income: S$556.5k (up from S$2.87m loss in FY 2024).
Profit margin: 2.0% (up from net loss in FY 2024).
EPS: S$0.001 (up from S$0.006 loss in FY 2024).
We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Livingstone Health Holdings shares are up 8.3% from a week ago.
Risk Analysis
Before you take the next step you should know about the 3 warning signs for Livingstone Health Holdings that we have uncovered.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
ELEGOO to Make IFA Debut, Bringing 3D Printing into Everyday Life
SHENZHEN, China, Aug. 20, 2025 /PRNewswire/ -- ELEGOO, a rapidly developing brand in global smart manufacturing, will participate for the first time at IFA 2025, held Sept. 1–5 at Messe Berlin (Hall 20-161). The company's debut at Europe's largest consumer electronics show underscores its mission to make 3D printing more accessible, affordable and enjoyable for everyday users. Since entering the 3D printing industry, ELEGOO has focused on democratizing 3D printing—transforming it from a niche, industrial tool into a household technology that empowers every-day creativity and solves real-life problems. "3D printing is no longer a complex, professional-only technology," said Chris Hong, Founder of ELEGOO. "IFA is a great platform to let people experience how intuitive, intelligent and inspiring this technology can be in daily life." Innovations on Display At Hall 20, Stand 161, visitors will see a strong slate of innovative printers: Centauri Carbon, OrangeStorm Giga, Saturn 4 Ultra 6K, Mars 5 Ultra and the European premiere of Jupiter 2, which will officially launch later this year. Centauri Carbon, iF DESIGN AWARD 2025 winner, is one of Elegoo's flagship FDM 3D printers that boasts a 25% faster speed than counterparts. The printing time of a normal cellphone case can be reduced to less than 30 minutes. Jupiter 2 is a large-format resin 3D printer that raises the bar with a 14-inch 16K LCD screen, achieving the series' highest 20×26µm XY resolution for razor-sharp details and ultra-smooth surfaces. All models combine high speed, precision and smart features to achieve user-friendly operations for all consumers while delivering professional-quality results. Visitors can experience the whole printing process using the displayed printers. Nexprint Platform and $1 Million Creator Fund Earlier this August, ELEGOO launched Nexprint, a creator platform designed to connect users worldwide and encourage sharing of original 3D models. The initiative is supported by a $1 million Creator Fund to reward innovative designs. Since 3D model files are the essential bridge between creativity and a printed object, the platform aims to simplify the most challenging step in the 3D printing process for consumers and inspire a new wave of creativity among beginners, hobbyists and professionals alike. Highlighting Diversity in Creation ELEGOO will also showcase the first phase of "ELEGOO with Her" program, which empowers women creators in home décor, education, fashion and cosplay. Seventy percent of participating designers in its first phase are new to 3D printing, reflecting the company's commitment to broadening access and fostering inclusivity in the maker community. A Booth Built by 3D Printing True to its vision, ELEGOO's booth will be designed as a 3D-printed living room where furniture and decorative pieces are all created by our printers. Also on display are prints that feature practical and creative solutions to everyday problems, showing how 3D printing can seamlessly integrate into home life. ELEGOO invites media representatives, industry professionals and consumers to visit Hall 20-161 to explore its products, discuss collaboration opportunities and experience first-hand how 3D printing is becoming part of everyday life. About Elegoo Founded in 2015, Elegoo is a rapidly developing brand in the global smart manufacturing industry, specializing in R&D, manufacturing, and sales of consumer-grade 3D printers, laser engravers, STEM kits, and other smart technology products. Located in Shenzhen, the Silicon Valley of China, the company has sold millions of products across more than 90 countries and regions. In 2024, the company's total sales revenue surpassed 200 million USD, with more than 700 employees and nearly 30,000 square meters of office and manufacturing area. With a focus on programming and 3D printing technology, Elegoo provides unique and smart creation spaces for diverse consumers to enhance personalized experiences. Get to know more about us at View original content to download multimedia: SOURCE Elegoo
Yahoo
26 minutes ago
- Yahoo
Hong Kong Exchange Posts Record Profit on IPO, Trading Surge
(Bloomberg) -- Hong Kong Exchanges and Clearing Ltd. delivered record profit in the second quarter as initial public offerings and trading boomed. The bourse's second-quarter profit rose 41% to HK$4.44 billion ($570 million), according to a statement Wednesday. Core revenue rose to HK$6.64 billion. Why New York City Has a Fleet of New EVs From a Dead Carmaker Chicago Schools Seeks $1 Billion of Short-Term Debt as Cash Gone Trump Takes Second Swing at Cutting Housing Assistance for Immigrants A Photographer's Pipe Dream: Capturing New York's Vast Water System A London Apartment Tower With Echoes of Victorian Rail and Ancient Rome Hong Kong's stock market has boomed this year, with its benchmark index surging and share sales posting a strong recovery as Chinese firms flock to raise capital. That in turn has boosted trading volumes, one of the main drivers of earnings for the exchange. Average daily turnover of equity products almost doubled in the period from a year earlier to HK$220 billion, according to the bourse. Southbound turnover, or flows from mainland China into Hong Kong, soared 154% while flows the other way to Shanghai and Shenzhen rose 19%. Share sales in Hong Kong have topped $46 billion this year, including a $5 billion deal from Contemporary Amperex Technology Co Ltd., according to Bloomberg-compiled data. Strong momentum is expected to carry through into the second half as more Chinese firms pivot to Hong Kong listings amid geopolitical turbulence. During the first half, 44 new listings debuted on HKEX, raising a total of HK$109.4 billion. The exchange had 207 active IPO applications at the end of June, more than double from the same period last year. 'While we celebrate these achievements, we must remain vigilant in the face of external uncertainties, including tariffs, geopolitical risks, and interest rate fluctuations,' said Chairman Carlson Tong in a statement. 'The bourse has also rolled out a series of measures to ease listings, including lowering revenue requirements and easing minimum float requirements, adding further momentum to the market.' HKEX's shares have risen 47% this year, beating the benchmark Hang Seng Index's gain of 24.5%. HKEX's corporate funds recorded a HK$1.044 billion net investment income in the first half, up 16% from a year earlier, in part on a 'non-recurring exchange gain' because of the appreciation of the US dollar against Hong Kong's counterpart, HKEX said. Net investment income from cash and bank deposits dropped 30% to HK$433 million. HKEX fully redeemed its external portfolio during the second quarter to pay for its permanent headquarters at Exchange Square, it said. The firm received HK$4.3 billion from the redemption in the first half and expecting another HK$600 million in the third quarter. The whole purchase will set HKEX back HK$6.3 billion, according to a statement in April. (Updates with details on IPO pipeline in sixth paragraph) Foreigners Are Buying US Homes Again While Americans Get Sidelined What Declining Cardboard Box Sales Tell Us About the US Economy Women's Earnings Never Really Recover After They Have Children Americans Are Getting Priced Out of Homeownership at Record Rates Survived Bankruptcy. Next Up: Cultural Relevance? ©2025 Bloomberg L.P. Sign in to access your portfolio
Business Upturn
29 minutes ago
- Business Upturn
Dr. Lal PathLabs becomes first in India to adopt AI-based module for cancer lymph node metastasis detection
Dr. Lal PathLabs has taken a groundbreaking step in advancing cancer diagnostics in India by becoming the first laboratory in the country to introduce a deep learning-based AI module for the detection of lymph node metastasis, including micrometastasis. This innovation, developed in collaboration with Singapore-based healthtech company Qritive, was recently showcased at USCAP 2025, one of the most prestigious pathology conferences in the world. The accurate detection of cancer spread to lymph nodes is a critical factor in determining the stage and treatment strategy for patients. Missing these signs of cancer progression can allow the disease to advance, increasing the chances of it spreading to distant organs and reducing survival rates. The ability to identify even occult metastases in patients with early-stage cancer has the potential to significantly influence treatment plans and improve outcomes. Traditionally, detecting micrometastases—small clusters of cancer cells hidden in lymph nodes—has been a time-consuming and complex process, often requiring advanced testing. The new AI system, called QiAI Lymph Node Dx, addresses this challenge by using deep learning to analyze digital slides and identify cancer cells with exceptional precision. This integration of AI into diagnostic practice ensures that cancer detection becomes faster, more reliable, and highly accurate. What makes this development especially impactful is its ability to pick up even single cancer cells, which were later validated through immunohistochemistry testing. The AI model has been tested across various cancer types, including breast, colon, stomach, and esophageal cancers, consistently delivering highly accurate results. Breast cancer, which accounts for nearly 28% of cancer cases among women in India, particularly stands to benefit from this breakthrough, highlighting the clinical relevance of the technology. By achieving complete sensitivity and negative predictive value—meaning no metastatic cases went undetected—the AI system has proven to be a robust screening tool. Its tumor-agnostic design allows it to function effectively across different cancer types, making it a versatile solution for oncologists and pathologists alike. As cancer incidence continues to rise in India, the integration of advanced AI-powered diagnostic tools such as QiAI Lymph Node Dx is set to transform the landscape of cancer care. By enabling earlier and more accurate diagnoses, this technology not only improves the efficiency of medical practice but also ensures better treatment decisions, offering renewed hope to patients battling cancer. Ahmedabad Plane Crash
